Shixin Xiang

717 total citations
17 papers, 540 citations indexed

About

Shixin Xiang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shixin Xiang has authored 17 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shixin Xiang's work include Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (3 papers) and CAR-T cell therapy research (2 papers). Shixin Xiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (3 papers) and CAR-T cell therapy research (2 papers). Shixin Xiang collaborates with scholars based in China, Hong Kong and Iran. Shixin Xiang's co-authors include Yueshui Zhao, Jing Shen, Xu Wu, Mingxing Li, Zhangang Xiao, Parham Jabbarzadeh Kaboli, Fukuan Du, Qinglian Wen, Chi Hin Cho and Qijie Zhao and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Gene.

In The Last Decade

Shixin Xiang

16 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shixin Xiang China	12	271	217	136	121	92	17	540
Xin Jing China	12	305 1.1×	173 0.8×	135 1.0×	106 0.9×	56 0.6×	28	554
Fatemeh Karimi Dermani Iran	7	247 0.9×	291 1.3×	145 1.1×	132 1.1×	73 0.8×	8	587
Dinoop Ravindran Menon United States	11	431 1.6×	239 1.1×	117 0.9×	131 1.1×	60 0.7×	19	631
Parisa Lotfinejad Iran	12	324 1.2×	223 1.0×	120 0.9×	192 1.6×	85 0.9×	18	610
Sarah McCuaig Canada	6	175 0.6×	237 1.1×	175 1.3×	72 0.6×	73 0.8×	8	487
Sarah T. Diepstraten Australia	10	439 1.6×	159 0.7×	118 0.9×	102 0.8×	55 0.6×	18	651
Souzan Najafi Iran	15	416 1.5×	226 1.0×	92 0.7×	254 2.1×	75 0.8×	35	726
Zhifeng Ning China	14	379 1.4×	174 0.8×	84 0.6×	138 1.1×	80 0.9×	18	569
Ajaya Kumar Reka United States	9	256 0.9×	145 0.7×	82 0.6×	135 1.1×	72 0.8×	10	524
Yang Cheng China	13	343 1.3×	142 0.7×	144 1.1×	194 1.6×	93 1.0×	25	621

Countries citing papers authored by Shixin Xiang

Since Specialization

Citations

This map shows the geographic impact of Shixin Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shixin Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shixin Xiang more than expected).

Fields of papers citing papers by Shixin Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shixin Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shixin Xiang. The network helps show where Shixin Xiang may publish in the future.

Co-authorship network of co-authors of Shixin Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shixin Xiang. A scholar is included among the top collaborators of Shixin Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shixin Xiang. Shixin Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhang, Duoli, Tao Zou, Jie Chen, et al.. (2023). Transcriptomic characterization revealed that METTL7A inhibits melanoma progression via the p53 signaling pathway and immunomodulatory pathway. PeerJ. 11. e15799–e15799. 3 indexed citations

Zhang, Zhenhua, Yueshui Zhao, Shixin Xiang, et al.. (2023). Analysis of clinicopathological factors affecting the chemoradiotherapy sensitivity in advanced cervical squamous cell carcinoma treated. European Journal of Gynaecological Oncology. 1 indexed citations

Xiang, Shixin, Yueshui Zhao, Xu Wu, et al.. (2023). Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network. Scientific Reports. 13(1). 4311–4311. 5 indexed citations

Wang, Fang, Duoli Zhang, Tao Zou, et al.. (2022). Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma. Frontiers in Immunology. 13. 1024931–1024931. 21 indexed citations

Kaboli, Parham Jabbarzadeh, Shuang Luo, Yao Chen, et al.. (2022). Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress. Gene. 816. 146171–146171. 13 indexed citations

Zhang, Yao, Shixin Xiang, Yueshui Zhao, et al.. (2021). Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer. Frontiers in Cellular and Infection Microbiology. 11. 599734–599734. 63 indexed citations

Zhao, Qijie, Yu Jiang, Shixin Xiang, et al.. (2021). Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons. Frontiers in Immunology. 12. 658753–658753. 110 indexed citations

Wan, Yue, Jing Li, Yueshui Zhao, et al.. (2021). Alterations in Intestinal Microbiota Composition in Mice Treated With Vitamin D3 or Cathelicidin. Frontiers in Oncology. 11. 700038–700038. 6 indexed citations

Xiang, Shixin, Jing Li, Jing Shen, et al.. (2021). Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Frontiers in Immunology. 12. 653836–653836. 64 indexed citations

10.

Kaboli, Parham Jabbarzadeh, Shixin Xiang, Qijie Zhao, et al.. (2020). Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy. Pharmacological Research. 156. 104806–104806. 121 indexed citations

11.

Li, Jing, Jing Shen, Ling Lin, et al.. (2020). Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer. Frontiers in Oncology. 10. 1474–1474. 13 indexed citations

12.

Zhang, Xinyue, Jinan Guo, Parham Jabbarzadeh Kaboli, et al.. (2020). <p>Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 7295–7304. 25 indexed citations

13.

Xiang, Shixin, Jing Shen, Yueshui Zhao, et al.. (2020). m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer. Frontiers in Molecular Biosciences. 7. 599340–599340. 24 indexed citations

14.

Li, Dan, Shixin Xiang, Jing Shen, et al.. (2020). Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets. International Journal of Biological Sciences. 16(4). 568–582. 26 indexed citations

15.

Zhao, Qijie, Jinan Guo, Yueshui Zhao, et al.. (2020). Comprehensive Assessment of PD-L1 and PD-L2 Dysregulation in Gastrointestinal Cancers. Epigenomics. 12(24). 2155–2171. 7 indexed citations

16.

Kaboli, Parham Jabbarzadeh, Lingling Zhang, Shixin Xiang, et al.. (2019). Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review. Current Medicinal Chemistry. 27(28). 4673–4698. 23 indexed citations

17.

Du, Fukuan, Yàn Li, Jing Shen, et al.. (2019). Glyoxalase 1 gene improves the antistress capacity and reduces the immune inflammatory response. BMC Genetics. 20(1). 95–95. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact